V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001599 | 230010604 | 1.65 | 84.8 | null | 2020-11-13 | 2020-12-19 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101790990 |
| 230001629 | 230010607 | 1.7 | 72.8 | null | 2020-10-23 | 2020-11-08 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101446426 |
| 230001634 | 230010608 | 1.68 | 125.1 | null | null | 2019-01-04 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101508613 |
| 230001645 | 230010609 | 1.56 | 70.3 | Palliative (P) | null | 2022-03-13 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101842029 |
| 230001653 | 230010611 | 1.56 | 69 | null | null | 2019-02-19 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101812817 |
| 230001654 | 230010612 | 1.63 | 77.8 | null | 2022-04-23 | 2022-04-24 | DABRAFENIB | 02 | null | TRIAL UNSPECIFIED | 100223869 |
| 230001669 | 230010615 | 0 | 72 | null | null | 2021-02-11 | null | null | null | FLUOROURACIL | 100283578 |
| 230001688 | 230010617 | 1.6 | 88.3 | null | 2020-09-24 | 2020-09-28 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100411615 |
| 230001696 | 230010620 | 1.67 | 91.7 | null | 2022-05-14 | 2022-05-24 | Niraparib | 02 | null | NIRAPARIB | 100908625 |
| 230001697 | 230010621 | 1.54 | 63.2 | Palliative (P) | null | 2018-09-22 | null | 01 | N | CARBOPLATIN + GEMCITABINE | 100546781 |
| 230001706 | 230010623 | 1.53 | 62.7 | Curative (C) | null | 2017-04-28 | Cisplatin + Etoposide po | N | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100983724 |
| 230001712 | 230010624 | 1.47 | 73.3 | Palliative (P) | null | 2020-03-31 | NIVOLUMAB | null | N | OLAPARIB | 100945253 |
| 230001732 | 230010629 | 1.57 | 89 | null | 2017-06-10 | 2017-06-10 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101640570 |
| 230001739 | 230010630 | 1.59 | 64.6 | null | null | 2022-03-21 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100856639 |
| 230001742 | 230010631 | null | null | null | null | 2017-02-23 | null | 99 | null | IPILIMUMAB | 100341122 |
| 230001768 | 230010633 | null | null | Palliative (P) | null | 2020-07-25 | Olaparib | 02 | N | OLAPARIB | 101335236 |
| 230001771 | 230010634 | 1.64 | 50.1 | Adjuvant (A) | null | 2022-05-19 | Niraparib | 02 | N | NIRAPARIB | 100089025 |
| 230001774 | 230010635 | 1.66 | 52.75 | Adjuvant (A) | 2021-03-24 | 2021-03-24 | null | null | N | CARBOPLATIN + GEMCITABINE | 101164593 |
| 230001809 | 230010639 | 1.6 | 113 | Palliative (P) | 2020-10-07 | 2020-10-13 | null | 02 | N | DOXORUBICIN | 100132664 |
| 230001810 | 230010640 | 1.52 | 74 | null | null | 2018-09-19 | null | null | null | GEMCITABINE | 101108378 |
| 230001815 | 230010642 | null | null | Adjuvant (A) | 2020-08-17 | 2020-11-24 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | Y | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101779065 |
| 230001835 | 230010645 | null | null | Palliative (P) | 2021-07-06 | 2021-07-11 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101058651 |
| 230001840 | 230010647 | 1.63 | 73.1 | null | null | 2021-07-16 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100630875 |
| 230001848 | 230010649 | null | null | null | 2021-09-01 | 2022-02-27 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101558616 |
| 230001863 | 230010650 | 1.52 | 49.6 | Palliative (P) | 2022-02-15 | 2022-03-05 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101006637 |
| 230001876 | 230010653 | null | null | null | 2020-11-25 | 2020-12-20 | PACLITAXEL | 02 | null | PACLITAXEL | 101241810 |
| 230001880 | 230010655 | 1.53 | 61 | null | 2021-01-08 | 2021-01-21 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101351228 |
| 230001886 | 230010656 | null | null | Palliative (P) | null | 2018-08-11 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100798503 |
| 230001890 | 230010657 | 1.66 | 42.25 | null | 2021-02-24 | 2022-04-02 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101429851 |
| 230001904 | 230010659 | null | null | 03 | 2021-12-28 | 2021-12-29 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 100900357 |
| 230001914 | 230010661 | 1.67 | 43.7 | null | 2019-04-30 | 2019-05-23 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100989179 |
| 230001915 | 230010662 | 1.45 | 56.3 | null | null | 2020-11-23 | PACLITAXEL | 02 | null | PACLITAXEL | 100824041 |
| 230001925 | 230010664 | 1.65 | 58 | null | 2021-11-27 | 2022-01-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100276572 |
| 230001939 | 230010666 | null | null | null | 2018-10-06 | 2018-10-07 | Olaparib | 02 | null | OLAPARIB | 100510619 |
| 230001941 | 230010668 | 1.6 | 69.8 | null | 2020-12-18 | 2021-01-11 | null | 02 | null | TRIAL UNSPECIFIED | 100644877 |
| 230001942 | 230010669 | 1.61 | 55 | Adjuvant (A) | null | 2020-11-29 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100920468 |
| 230001945 | 230010670 | null | null | null | 2022-05-14 | 2022-05-14 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101799109 |
| 230001947 | 230010671 | null | null | null | 2020-12-16 | 2020-12-20 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | TRIAL UNSPECIFIED | 100662507 |
| 230001957 | 230010674 | 1.68 | 63.8 | Palliative (P) | 2019-12-23 | 2019-12-29 | null | null | N | ICON8B TRIAL | 100273956 |
| 230001959 | 230010675 | 1.63 | 48.6 | null | 2021-03-31 | 2021-09-17 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 100633551 |
| 230001971 | 230010677 | 1.47 | 110.6 | null | 2021-09-04 | 2021-09-27 | null | 02 | null | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 101171132 |
| 230001982 | 230010679 | 1.68 | 79.7 | null | 2015-11-24 | 2018-07-28 | null | 2 | null | DOCETAXEL | 101163629 |
| 230001986 | 230010680 | 1.78 | 97.6 | Palliative (P) | null | 2021-04-28 | null | null | N | PACLITAXEL | 101362307 |
| 230001988 | 230010681 | 1.58 | 58 | null | 2020-07-25 | 2022-05-07 | Niraparib | 02 | null | NIRAPARIB | 100478120 |
| 230001999 | 230010682 | 1.52 | 62.7 | null | 2021-09-15 | 2022-01-14 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100523889 |
| 230002027 | 230010686 | 1.62 | 50.8 | null | 2020-10-10 | 2020-10-19 | null | Y | null | NIRAPARIB | 101310432 |
| 230002031 | 230010687 | null | null | null | 2022-03-27 | 2022-05-13 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101678575 |
| 230002050 | 230010690 | 1.76 | 65.9 | null | 2019-11-19 | 2019-11-22 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101559296 |
| 230002053 | 230010691 | 1.73 | 87.05 | Palliative (P) | null | 2021-07-30 | Cyclophosphamide + Vincristine | 02 | N | TRIAL UNSPECIFIED | 100269365 |
| 230002064 | 230010692 | 1.6 | 64.3 | null | 2021-04-27 | 2021-05-08 | NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100781182 |